Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Publication year range
1.
Chin J Nat Med ; 17(6): 424-434, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31262455

ABSTRACT

To examine the effects of Populus tomentiglandulosa (PT) extract on the expressions of antioxidant enzymes and neurotrophic factors in the cornu ammonis 1 (CA1) region of the hippocampus at 5 min after inducing transient global cerebral ischemia (TGCI) in gerbils, TGCI was induced by occlusion of common carotid arteries for 5 min. Before ischemic surgery, 200 mg·kg-1 PT extract was orally administrated once daily for 7 d. We performed neuronal nuclear antigen immunohistochemistry and Fluoro-Jade B staining. Furthermore, we determined in situ production of superoxide anion radical, expression levels of SOD1 and SOD2 as antioxidant enzymes and brain-derived neurotrophic factor (BDNF) and insulin-like growth factor I (IGF-I) as neurotrophic factors. Pretreatment with 200 mg·kg-1 PT extract prevented neuronal death (loss). Furthermore, pretreatment with 200 mg·kg-1 PT extract significantly inhibited the production of superoxide anion radical, increased expressions of SODs and maintained expressions of BDNF and IGF-I. Such increased expressions of SODs were maintained in the neurons after IRI. In summary, pretreated PT extract can significantly increase levels of SODs and protect the neurons against TGCI, suggesting that PT can be a useful natural agent to protect against TGCI.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , CA1 Region, Hippocampal/drug effects , Insulin-Like Growth Factor I/metabolism , Plant Extracts/administration & dosage , Populus/chemistry , Pyramidal Cells/drug effects , Reperfusion Injury/drug therapy , Superoxide Dismutase/metabolism , Animals , Brain-Derived Neurotrophic Factor/genetics , CA1 Region, Hippocampal/metabolism , Gerbillinae , Humans , Insulin-Like Growth Factor I/genetics , Male , Neuroprotective Agents/administration & dosage , Pyramidal Cells/metabolism , Reperfusion Injury/genetics , Reperfusion Injury/metabolism , Superoxide Dismutase/genetics , Up-Regulation/drug effects
2.
Int J Mol Sci ; 20(6)2019 Mar 21.
Article in English | MEDLINE | ID: mdl-30901885

ABSTRACT

In recent years, the use of botanical agents to prevent skin damage from solar ultraviolet (UV) irradiation has received considerable attention. Oenanthe javanica is known to exert anti-inflammatory and antioxidant activities. This study investigated photoprotective properties of an Oenanthe javanica extract (OJE) against UVB-induced skin damage in ICR mice. The extent of skin damage was evaluated in three groups: control mice with no UVB, UVB-exposed mice treated with vehicle (saline), and UVB-exposed mice treated with 1% extract. Photoprotective properties were assessed in the dorsal skin using hematoxylin and eosin staining, Masson trichrome staining, immunohistochemical staining, quantitative real-time polymerase chain reaction, and western blotting to analyze the epidermal thickness, collagen expression, and mRNA and protein levels of type I collagen, type III collagen, and interstitial collagenases, including matrix metalloproteinase (MMP)-1 and MMP-3. In addition, tumor necrosis factor (TNF)-α and cyclooxygenase (COX)-2 protein levels were also assessed. In the UVB-exposed mice treated with extract, UV-induced epidermal damage was significantly ameliorated. In this group, productions of collagen types I and III were increased, and expressions of MMP-1 and MMP-3 were decreased. In addition, TNF-α and COX-2 expressions were reduced. Based on these findings, we conclude that OJE displays photoprotective effects against UVB-induced collagen disruption and inflammation and suggest that Oenanthe javanica can be used as a natural product for the treatment of photodamaged skin.


Subject(s)
Collagen/metabolism , Oenanthe/chemistry , Plant Extracts/pharmacology , Protective Agents/pharmacology , Skin/drug effects , Skin/metabolism , Skin/radiation effects , Ultraviolet Rays/adverse effects , Animals , Biomarkers , Biopsy , Dermatitis/drug therapy , Dermatitis/etiology , Dermatitis/metabolism , Disease Models, Animal , Gene Expression , Immunohistochemistry/methods , Mice , Plant Extracts/chemistry , Protective Agents/chemistry
3.
Nutrients ; 12(1)2019 Dec 30.
Article in English | MEDLINE | ID: mdl-31905851

ABSTRACT

(1) Background: By 2050, it is estimated that 130 million people will be diagnosed with dementia, and currently approved medicines only slow the progression. So preventive intervention is important to treat dementia. Mild cognitive impairment is a condition characterized by some deterioration in cognitive function and increased risk of progressing to dementia. Therefore, the treatment of mild cognitive impairment (MCI) is a possible way to prevent dementia. Angelica gigas reduces neuroinflammation, improves circulation, and inhibits cholinesterase, which can be effective in the prevention of Alzheimer's disease and vascular dementia and the progression of mild cognitive impairment. (2) Methods: Angelica gigas (AG) extract 1 mg/kg was administered to mildly cognitive impaired mice, models based on mild traumatic brain injury and chronic mild stress. Then, spatial, working, and object recognition and fear memory were measured. (3) Result: Angelica gigas improved spatial learning, working memory, and suppressed fear memory in the mild traumatic brain injury model. It also improved spatial learning and suppressed cued fear memory in the chronic mild stress model animals. (4) Conclusions: Angelica gigas can improve cognitive symptoms in mild cognitive impairment model mice.


Subject(s)
Angelica/physiology , Cognitive Dysfunction/drug therapy , Memory/drug effects , Plant Extracts/therapeutic use , Animals , Conditioning, Psychological , Fear , Male , Mice , Mice, Inbred C57BL , Plant Extracts/pharmacology , Random Allocation , Stress, Physiological
SELECTION OF CITATIONS
SEARCH DETAIL